LAMICTAL
ARIPIPRAZOLE
CARBAMAZEPINE
LITHIUM
OLANZAPINE
QUETIAPINE
RISPERIDONE
SSRI
TOPIRAMATE
VALPROATE
ZIPRASIDONE
LAMICTAL
FRANCE
Marketing information
Key claims
Country information
United Kingdom
Germany
Spain
Italy
France
References
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
France
Proposed indication:
For the prevention of depressive episodes in patients with bipolar disorder.
Brand name:
Lamictal.
Regulatory status:
Pending.
Launch date:
Estimated April 2004.
